About lab
Abstract:Despite intensive treatments including temozolomide (TMZ) administration, glioblastoma patient prognosis remains dismal and innovative therapeutic strategies are urgently needed. It can be used to explore systemsbiology stephanou2019 ph as a potential dynamics and compare simulation behavior across conditions.
Runtime
Duration1
Comms Step0.1
Runs
Total0
Completed0
Failed0
Metadata
Packagestephanou2019-ph-as-a-potential-therapeutic-target-to-improve-te
Created2026-05-17
Updated2026-05-17
oncologysystemsbiologysbmlbiomodels_ebifaithfulcuratedvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_mtic_m_i",
"label": "Initial Mtic M I",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.initial_mtic_m_i",
"description": "Source state initial condition exposed as a model-specific control because no explicit intervention parameter is identifiable. Maps to SBML symbol `MTIC_M_i`."
},
{
"name": "initial_dna_adducts",
"label": "Initial DNA Adducts",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.initial_dna_adducts",
"description": "Source state initial condition exposed as a model-specific control because no explicit intervention parameter is identifiable. Maps to SBML symbol `DNA_adducts`."
},
{
"name": "initial_cation_c_i",
"label": "Initial Cation C I",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.initial_cation_c_i",
"description": "Source state initial condition exposed as a model-specific control because no explicit intervention parameter is identifiable. Maps to SBML symbol `Cation_C_i`."
},
{
"name": "initial_tmz_intracellular_dynamics_t_i",
"label": "Initial Tmz Intracellular Dynamics T I",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.initial_tmz_intracellular_dynamics_t_i",
"description": "Source state initial condition exposed as a model-specific control because no explicit intervention parameter is identifiable. Maps to SBML symbol `TMZ_intracellular_dynamics_T_i`."
},
{
"name": "initial_tmz_extracellular_concentration_t_o",
"label": "Initial Tmz Extracellular Concentration T O",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.initial_tmz_extracellular_concentration_t_o",
"description": "Source state initial condition exposed as a model-specific control because no explicit intervention parameter is identifiable. Maps to SBML symbol `TMZ_extracellular_concentration_T_o`."
}
],
"outputs": [
{
"name": "state",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.state"
},
{
"name": "summary",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.summary"
},
{
"name": "species_labels",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.species_labels"
},
{
"name": "mtic_m_i",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.mtic_m_i"
},
{
"name": "dna_adducts",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.dna_adducts"
},
{
"name": "cation_c_i",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.cation_c_i"
},
{
"name": "tmz_intracellular_dynamics_t_i",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.tmz_intracellular_dynamics_t_i"
},
{
"name": "tmz_extracellular_concentration_t_o",
"maps_to": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.tmz_extracellular_concentration_t_o"
}
]
},
"tags": [
"oncology",
"systemsbiology",
"sbml",
"biomodels_ebi",
"faithful",
"curated"
],
"title": "Stephanou2019 Ph As A Potential Therapeutic Target To Improve Temozolomi Lab",
"models": [
{
"path": "owned/models/systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model",
"alias": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model",
"provenance": {
"owned_path": "owned/models/systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model_state"
],
"from": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.state"
},
{
"to": [
"visualisation.systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model_summary"
],
"from": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.summary"
},
{
"to": [
"visualisation.systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model_species_labels"
],
"from": "systemsbiology_sbml_stephanou2019_ph_as_a_potential_therapeutic_targ_model1909300003_model.species_labels"
}
],
"runtime": {
"duration": 1,
"initial_inputs": {},
"communication_step": 0.1
},
"description": "Abstract:Despite intensive treatments including temozolomide (TMZ) administration, glioblastoma patient prognosis remains dismal and innovative therapeutic strategies are urgently needed. It can be used to explore systemsbiology stephanou2019 ph as a potential dynamics and compare simulation behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.